Hikal Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Hikal Ltd · Financial Result · 03 Nov 2026, 7:54 pm
Hikal Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 4,342 (+36.3% YoY | +7.8% QoQ) ■ EBITDA: 449 (+523.6% YoY | +21.4% QoQ) ■ EBITDA Margin (%): 10.3 (+808 bps YoY | +116 bps QoQ) ■ PAT: -61.0 (+82.5% YoY | +17.6% QoQ) ■ EPS (INR): -0.49 (+82.7% YoY | +18.3% QoQ) Hikal Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Pharmaceuticals ■ Revenue: 2,778 (+46.6% YoY | +19.1% QoQ) ■ EBIT: 128 (Loss to Profit YoY | +70.7% QoQ) ■ EBIT Margin (%): 4.6 (Loss to Profit YoY | +139 bps QoQ) Crop protection and speciality ingredients ■ Revenue: 1,564 (+21.2% YoY | -7.7% QoQ) ■ EBIT: -23.0 (+76.0% YoY | +61.7% QoQ) ■ EBIT Margin (%): -1.5 (+597 bps YoY | +207 bps QoQ)
Original exchange filing (PDF)
More announcements from Hikal Ltd
- Transcript of Earnings Call for the Quarter and half year ended September 30, 2026. · 05 Nov 2026
- Audio Recording of Group Conference call for the quarter and half year ended September 30, 2026. · 04 Nov 2026
- Result presentation for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Announcement under Regulation 30 of SEBI LODR 2015- Press Release on the results of the Company for the quarter and half year ended September 30, 2026. · 03 Nov 2026
- Pursuant to Regulation 30(5) of the SEBI LODR Regulations- List of KMP authorized to determine materiality and make disclosures. · 03 Nov 2026
- Unaudited Financial Results for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Hikal Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 03 Nov 2026
- Press Release on Hikal signs Multi-Year Global CDMO contract with leading Agrochemical Company · 02 Nov 2026
